Have a feature idea you'd love to see implemented? Let us know!

TOI Oncology Institute Inc

Price (delayed)

$0.2999

Market cap

$22.64M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.79

Enterprise value

$107.22M

Highlights
TOI's revenue is up by 23% year-on-year and by 5% since the previous quarter
The quick ratio has grown by 12% YoY and by 5% from the previous quarter
The EPS has contracted by 18% YoY but it has grown by 2.5% from the previous quarter
TOI's equity has dropped by 66% year-on-year and by 29% since the previous quarter
The gross margin has contracted by 23% YoY and by 9% from the previous quarter

Key stats

What are the main financial stats of TOI
Market
Shares outstanding
75.49M
Market cap
$22.64M
Enterprise value
$107.22M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.76
Price to sales (P/S)
0.06
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.3
Earnings
Revenue
$361.07M
EBIT
-$50.97M
EBITDA
-$44.69M
Free cash flow
-$47.97M
Per share
EPS
-$0.79
Free cash flow per share
-$0.64
Book value per share
$0.39
Revenue per share
$4.83
TBVPS
$2.09
Balance sheet
Total assets
$179.6M
Total liabilities
$150.4M
Debt
$121.01M
Equity
$29.21M
Working capital
$81.11M
Liquidity
Debt to equity
4.14
Current ratio
3.31
Quick ratio
2.87
Net debt/EBITDA
-1.89
Margins
EBITDA margin
-12.4%
Gross margin
15.3%
Net margin
-15.6%
Operating margin
-17.6%
Efficiency
Return on assets
-27.8%
Return on equity
-113.1%
Return on invested capital
-22.4%
Return on capital employed
-35.3%
Return on sales
-14.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TOI stock price

How has the Oncology Institute stock price performed over time
Intraday
-3.26%
1 week
-7.81%
1 month
-6.43%
1 year
-85.72%
YTD
-85.3%
QTD
-8.26%

Financial performance

How have Oncology Institute's revenue and profit performed over time
Revenue
$361.07M
Gross profit
$55.35M
Operating income
-$63.55M
Net income
-$56.35M
Gross margin
15.3%
Net margin
-15.6%
Oncology Institute's operating margin has increased by 45% YoY and by 2.8% from the previous quarter
The operating income rose by 32% year-on-year but it has declined by 2.3% since the previous quarter
The company's net margin rose by 25% YoY and by 8% QoQ
The gross margin has contracted by 23% YoY and by 9% from the previous quarter

Growth

What is Oncology Institute's growth rate over time

Valuation

What is Oncology Institute stock price valuation
P/E
N/A
P/B
0.76
P/S
0.06
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.3
The EPS has contracted by 18% YoY but it has grown by 2.5% from the previous quarter
TOI's equity has dropped by 66% year-on-year and by 29% since the previous quarter
The stock's P/B is 62% less than its last 4 quarters average of 2.0
The P/S is 96% less than the 5-year quarterly average of 1.6 and 80% less than the last 4 quarters average of 0.3
TOI's revenue is up by 23% year-on-year and by 5% since the previous quarter

Efficiency

How efficient is Oncology Institute business performance
The company's return on equity has shrunk by 102% YoY and by 25% QoQ
The ROS has grown by 23% YoY and by 8% from the previous quarter
The ROA is down by 16% year-on-year and by 3.7% since the previous quarter
The company's return on invested capital fell by 11% YoY

Dividends

What is TOI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TOI.

Financial health

How did Oncology Institute financials performed over time
The total assets is 19% more than the total liabilities
The total assets has contracted by 22% YoY and by 12% from the previous quarter
The quick ratio has grown by 12% YoY and by 5% from the previous quarter
TOI's equity has dropped by 66% year-on-year and by 29% since the previous quarter
The debt to equity has grown by 43% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.